Log In
BCIQ
Print this Print this
 

XMetA

  Manage Alerts
Collapse Summary General Information
Company Xoma Corp.
DescriptionHuman allosteric mAb that activates the insulin receptor (INSR)
Molecular Target Insulin receptor (INSR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationDiabetes
Indication DetailsTreat diabetes
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$295.0M

$5.0M

$290.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/01/2015

$295.0M

$5.0M

$290.0M

Get a free BioCentury trial today